Canada markets closed

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4600+0.0100 (+0.69%)
At close: 03:59PM EST
1.4600 0.00 (0.00%)
After hours: 04:00PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 17.13M
Enterprise Value -17.01M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.53
Enterprise Value/Revenue 105.22
Enterprise Value/EBITDA 0.46

Trading Information

Stock Price History

Beta (5Y Monthly) 1.41
52-Week Change 3-76.19%
S&P500 52-Week Change 3-7.13%
52 Week High 37.0500
52 Week Low 30.6010
50-Day Moving Average 31.1381
200-Day Moving Average 32.4427

Share Statistics

Avg Vol (3 month) 3372.49k
Avg Vol (10 day) 391.54k
Shares Outstanding 512.23M
Implied Shares Outstanding 6N/A
Float 812.14M
% Held by Insiders 10.73%
% Held by Institutions 12.69%
Shares Short (Jan 12, 2023) 4355.29k
Short Ratio (Jan 12, 2023) 40.38
Short % of Float (Jan 12, 2023) 42.94%
Short % of Shares Outstanding (Jan 12, 2023) 42.90%
Shares Short (prior month Dec 14, 2022) 4139.85k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Aug 17, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-21.54%
Return on Equity (ttm)-102.42%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -26.15M
Net Income Avi to Common (ttm)-43.53M
Diluted EPS (ttm)0.1300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)64.36M
Total Cash Per Share (mrq)5.26
Total Debt (mrq)31.8M
Total Debt/Equity (mrq)97.71
Current Ratio (mrq)8.88
Book Value Per Share (mrq)2.66

Cash Flow Statement

Operating Cash Flow (ttm)-16.67M
Levered Free Cash Flow (ttm)-14.93M